ReviewSeminars in radiation oncology2022
The Evolution of Geriatric Oncology and Geriatric Assessment over the Past Decade.
Review in Seminars in radiation oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.
- Treatment delay significantly increases mortality in colorectal cancer: a meta-analysis.GeroScience · 2025Pooled it
- Concurrent nimotuzumab and intensity-modulated radiotherapy for elderly patients with locally advanced nasopharyngeal carcinoma.Cancer science · 2024Trial
- Comprehensive assessment in uro-oncologic geriatric patients: interdisciplinary management to improve survival.International urology and nephrology · 2025Review
- Correlation between metabolic syndrome indicators and locomotive syndrome in Chinese geriatric oncology inpatients.Frontiers in medicine · 2025Article
- Implementation of an Oncogeriatric Unit for Frail Older Patients with Breast Cancer: Preliminary Results.Current oncology (Toronto, Ont.) · 2024Article
- Geriatric Oncology: A 5-Year Strategic Plan.American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · 2024Review
- Tailoring Therapy in Older Adults With Hematologic Malignancies.American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · 2024Review
- Evaluation of New Generation Sequencing (NGS)-Based Somatic Gene Variations and Real-Time Polymerase Chain Reaction (PCR)-Based Gene Fusions in Elderly and Young Acute Leukemia Patients: A Retrospective View.Journal of personalized medicine · 2024Article
- Geriatric Assessment of Older Adults With Cancer During Acute Hospitalizations: Challenges and Opportunities.Cureus · 2023Article
- The Role of Nurse on the Treatment Decision Support for Older People with Cancer: A Systematic Review.Healthcare (Basel, Switzerland) · 2023Review
- Examining provider perceptions and practices for comprehensive geriatric assessment among cancer survivors: a qualitative study with an implementation science focus.Frontiers in aging · 2023Article
- A model for the uptake of advance care planning in older cancer adults: a scoping review.Aging clinical and experimental research · 2022Article
- Geriatric Oncology in Portugal: Where We Are and What Comes Next-A Survey of Healthcare Professionals.Geriatrics (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 10 institutions in 6 countries.
Funding
Abstract
Cancer is predominantly a disease of aging, and older adults represent the majority of cancer diagnoses and deaths. Older adults with cancer differ significantly from younger patients, leading to important distinctions in cancer treatment planning and decision-making. As a consequence, the field of geriatric oncology has blossomed and evolved over recent decades, as the need to bring personalized cancer care to older adults has been increasingly recognized and a focus of study. The geriatric assessment (GA) has become the cornerstone of geriatric oncology research, and the past year has yielded promising results regarding the implementation of GA into routine cancer treatment decisions and outcomes for older adults. In this article, we provide an overview of the field of geriatric oncology and highlight recent breakthroughs with the use of GA in cancer care. Further work is needed to continue to provide personalized, evidence-based care for each older adult with cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.